Metastasis-directed therapy may prolong progression-free survival in prostate cancer
CANCER DIGEST – Nov. 12, 2022 – For patients with prostate cancer that has spread to a single site outside the prostate, a therapy...
Adding drug to androgen suppression boosts progression-free survival in prostate cancer
CANCER DIGEST – Nov. 6, 2022 – An investigational therapy increased progression-free survival in 40 percent of nine patients whose...
